NEW YORK, Oct. 2, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cocrystal Pharma, Inc. ("Cocrystal" or the "Company") (NASDAQ: COCP) (f/k/a BioZone Pharmaceuticals, Inc. ("BioZone"). Such investors are advised to contact Robert S. Willoughby at rswill...
from PR Newswire: //https://ift.tt/2O4QsG4
No comments:
Post a Comment